Antonio Regalado

You are currently browsing articles tagged Antonio Regalado.

astronauts1231 (2)

recent post concerned Liz Parrish, the BioViva CEO, who surprisingly announced herself as patient zero for the company’s experimental youth-restoring gene therapies, a move whose specifics are shrouded in secrecy. This treatment will not be cheap and widely available in three years, despite what the firm says, but many other questions are left unanswered. Antonio Regalado of Technology Review looks into the turbulent aftermath of the shocking proclamation. An excerpt:

Elizabeth Parrish, the 44-year-old CEO of a biotechnology startup called BioViva, says she underwent a gene therapy at an undisclosed location overseas last month, a first step in what she says is a plan to develop treatments for ravages of old age like Alzheimer’s and muscle loss. “I am patient zero,” she declared during a Q&A on the website Reddit on Sunday. “I have aging as a disease.”

Since last week, MIT Technology Review has attempted to independently verify the accuracy of Parrish’s claims, particularly how she obtained the genetic therapy. While many key details could not be confirmed, people involved with her company said the medical procedure took place September 15 in Colombia.

The experiment seems likely to be remembered as either a new low in medical quackery or, perhaps, the unlikely start of an era in which people receive genetic modifications not just to treat disease, but to reverse aging. It also raises ethical questions about how quickly such treatments should be tested in people and whether they ought to be developed outside the scrutiny of regulators. The field of anti-aging research is known for attracting a mix of serious scientists, vitamin entrepreneurs, futurists, and cranks peddling various paths to immortality, including brain freezing.

Parrish’s assertions set off a scramble among members of her company’s scientific advisory board to understand what had occurred. •

Tags: ,

As the above photos attest, Homo sapiens is not a perfect species. Gene therapy could change that.

Altering the code of those with a specific illness embedded in the “alphabet” of who they are is an area of great promise. But what if those changes to DNA could be made hereditary? What if we “optimize” humans across generations to not only be rid of disease but to increase intelligence and strength and to weed out characteristics that are considered unfavorable at this moment in history? Will we make things worse while trying to make them better? It’s a pretty sure bet that if we don’t destroy ourselves in the short run with greenhouse gases or by some other means, we’ll have to work through these questions. The opening of “Engineering the Perfect Baby,” Antonio Regalado’s Technology Review inquiry into the future of parenting:

If anyone had devised a way to create a genetically engineered baby, I figured George Church would know about it.

At his labyrinthine laboratory on the Harvard Medical School campus, you can find researchers giving E. Coli a novel genetic code never seen in nature. Around another bend, others are carrying out a plan to use DNA engineering to resurrect the woolly mammoth. His lab, Church likes to say, is the center of a new technological genesis—one in which man rebuilds creation to suit himself.

When I visited the lab last June, Church proposed that I speak to a young postdoctoral scientist named Luhan Yang, a Harvard recruit from Beijing who’d been a key player in developing a new, powerful technology for editing DNA called CRISPR-Cas9. With Church, Yang had founded a small company to engineer the genomes of pigs and cattle, sliding in beneficial genes and editing away bad ones.

As I listened to Yang, I waited for a chance to ask my real questions: Can any of this be done to human beings? Can we improve the human gene pool? The position of much of mainstream science has been that such meddling would be unsafe, irresponsible, and even impossible. But Yang didn’t hesitate. Yes, of course, she said. In fact, the Harvard laboratory had a project to determine how it could be achieved. She flipped open her laptop to a PowerPoint slide titled “Germline Editing Meeting.”

Here it was: a technical proposal to alter human heredity.

“Germ line” is biologists’ jargon for the egg and sperm, which combine to form an embryo. By editing the DNA of these cells or the embryo itself, it could be possible to eliminate disease genes and to pass those genetic fixes on to future generations. Such a technology could be used to rid families of scourges like cystic fibrosis. It might also be possible to install genes that offer lifelong protection against infection, Alzheimer’s, and, Yang told me, maybe the effects of aging. These would be history-making medical advances that could be as important to this century as vaccines were to the last.

That’s the promise. The fear is that germ line engineering is a path toward a dystopia of super people and designer babies for those who can afford it.•

Tags: , ,

So-called anticipatory systems bring Big Data to a micro-level, providing you with near-term knowledge you couldn’t find on your own in exchange for you handing over all your personal info so that companies can better target you for ads and who knows what else. It’s convenience at a cost. From Antonio Regalado at MIT’s Technology Review:

“Would you trade your personal data for a peek into the future? Andreas Weigend did.

The former chief scientist of Amazon.com, now directing Stanford University’s Social Data Lab, told me a story about awakening at dawn to catch a flight from Shanghai. That’s when an app he’d begun using, Google Now, told him his flight was delayed.

The software scours a person’s Gmail and calendar, as well as databases like maps and flight schedules. It had spotted the glitch in his travel plans and sent the warning that he shouldn’t rush. When Weigend finally boarded, everyone else on the plane had been waiting for hours for a spare part to arrive.

For Weigend, a fast-talking consultant and lecturer on consumer behavior, such episodes demonstrate ‘the power of a society based on 10 times as much data.’ If the last century was marked by the ability to observe the interactions of physical matter—think of technologies like x-ray and radar—this century, he says, is going to be defined by the ability to observe people through the data they share.”

Tags:

The opening of “The Most Important Education Technology in 200 Years,” Antonio Regalado’s MIT’s Technology Review article about the advent of limitless admissions:

“If you were asked to name the most important innovation in transportation over the last 200 years, you might say the combustion engine, air travel, Henry Ford’s Model-T production line, or even the bicycle. The list goes on.

Now answer this one: what’s been the single biggest innovation in education?

Don’t worry if you come up blank. You’re supposed to. The question is a gambit used by Anant Agarwal, the computer scientist named this year to head edX, a $60 million MIT-Harvard effort to stream a college education over the Web, free, to anyone who wants one. His point: it’s rare to see major technological advances in how people learn.

Agarwal believes that education is about to change dramatically. The reason is the power of the Web and its associated data-crunching technologies. Thanks to these changes, it’s now possible to stream video classes with sophisticated interactive elements, and researchers can scoop up student data that could help them make teaching more effective. The technology is powerful, fairly cheap, and global in its reach. EdX has said it hopes to teach a billion students.”

Tags:

Two teams hope to send DNA-sequencing machines to Mars to prove the Red Planet harbors life. One of the groups is led by Craig Venter, who believes in building better bugs. From Antonio Regalado at MIT Technology Review:

“Although neither team yet has a berth on Mars rocket, their plans reflect the belief that the simplest way to prove there is life on Mars is to send a DNA sequencing machine.

‘There will be DNA life forms there,’ Venter predicted Tuesday in New York, where he was speaking at the Wired Health Conference.

Venter said researchers working with him have already begun tests at a Mars-like site in the Mojave Desert. Their goal, he said, is to demonstrate a machine capable of autonomously isolating microbes from soil, sequencing their DNA, and then transmitting the information to a remote computer, as would be required on an unmanned Mars mission. Heather Kowalski, a spokeswoman for Venter, confirmed the existence of the project but said the prototype system was ‘not yet 100 percent robotic.'”

Tags: , ,